检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Standard brentuximab vedotin schedule vs early discontinuation on clinician's decision in patients with CTCL: a multicenter, retrospective study from the FIL Cutaneous Lymphomas Task Force

Vieri Grandi,Erika Morsia,Annagiulia Zizzari,Giacomo Loseto,Paolo Fava, Nicole Macagno,Silvia Alberti Violetti,Francesca Cavallaro,Alessandro Pileri,Alessandro Broccoli,Paola Vitiello,Antonello Sica,Marianna Palazzo,Luca Nassi,Pietro Quaglino,Serena Rupoli,Emilio Berti,Francesco Onida,Pier Luigi Zinzani,Nicola Pimpinelli

EUROPEAN JOURNAL OF CANCER（2023）

引用 0|浏览4
暂无评分
关键词
standard brentuximab vedotin schedule,lymphomas,ctcl,early discontinuation
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要